retatrutide type 2 diabetes trial 2024 improves blood sugar and weight loss in Retatrutide Phase 2: Type 2

Another study showed that people taking Wegovy lost an average of 1520% of their body weight in clinical trials, especially when combined with healthy eating and exercise

In trials it outperforms Tirzepatide for weight loss

A national observation study of cancer incidence and mortality risks in type 2 diabetes compared to the background population over time

By the time the pandemic hit, LifeVantage was poised to benefit from fear and confusion around this new health threat, as well as a newly remote labor pool

Micronutrient deficiency in obese subjects undergoing low calorie diet

Questions around peak potential have emerged, but concerns may be overstated